Does Dr. VENKATESH KRISHNASAMY have financial conflicts of interest?

Dr. VENKATESH KRISHNASAMY (M.D.) has received a total of $232,226 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $232,226 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VENKATESH KRISHNASAMY?

According to CMS Open Payments data, Dr. VENKATESH KRISHNASAMY received funding from BOSTON SCIENTIFIC CORPORATION ($48,907), DELCATH SYSTEMS ($42,400), and COOK INCORPORATED ($30,424).

Does Dr. VENKATESH KRISHNASAMY receive research grants or speaking fees?

Dr. VENKATESH KRISHNASAMY has received $232,226 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VENKATESH KRISHNASAMY

M.D.Real-Time Hydrated

Specialty: Radiology, Vascular & Interventional Radiology

Practice Location: BIRMINGHAM, AL 35249

NPI Number: 1932307295

LIFETIME INDUSTRY VALUE

$232,226

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. KRISHNASAMY is a verified Radiology, Vascular & Interventional Radiology practitioner based in BIRMINGHAM, AL.

Between 2021 and 2025, Dr. KRISHNASAMY had an overall industry promotional and research financial footprint of $232,226 as recorded in the federal CMS Open Payments database.

$232,226 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. KRISHNASAMY's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $48,907 (representing 21.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$48,907

21.1%

DELCATH SYSTEMS

Rank 2

$42,400

18.3%

COOK INCORPORATED

Rank 3

$30,424

13.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.